Leukemia pioneers honored
The University of Minnesota Medical Alumni Society honored two prominent leukemia doctors with the lifetime achievement Harold S. Diehl Award at a special banquet on October 28. The award is granted to individuals who have made outstanding contributions to the Medical School, the University as a whole and the community.
John H. Kersey, M.D.
As founding director of what is now known as the Masonic Cancer Center, John Kersey has always been a forward-thinker and collaborator with his peers, leading the team that performed the world’s first successful bone marrow transplant for treating lymphoma. Since stepping down as Masonic Cancer Center director in 2007, Kersey has returned to the lab to pursue a cure for acute lymphoblastic leukemia.
Mark. E. Nesbit Jr., M.D.
Mark Nesbit is a pioneer in the treatment of acute leukemia, setting the standard of care for children and adults who have leukemia and other cancers. Described by his peers as an astute clinician, researcher, teacher and advocate, Nesbit also served as the first board chair of Children’s Cancer Research Fund.